author-photo

Anne S. Tsao

University of Texas MD Anderson Cancer Center

121

Papers

3796

Citations

Citation Trend

Filter By

Papers (121) Sort By

Journal Conference Others

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

2021 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (38)
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations From a Phase 1/2 Trial.

2021 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (35)
Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Feasibility of a Group-based Telehealth Psychosocial Intervention for Women with Non-Small Cell Lung Cancer (NSCLC)

2021 Cancer Epidemiology and Prevention Biomarkers
Show All
- Source
- Cite
- Save
Citations (0)
Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (9)
Outcomes of Critically Ill Lung Cancer Patients Initiating Targeted Therapy or Immunotherapy in the Intensive Care Unit: A Single-Center Report.

2021 Journal of Intensive Care Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Extrapleural Pneumonectomy versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma.

2021 The Annals of Thoracic Surgery
Show All
- Source
- Cite
- Save
Citations (1)
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling.

2021
Show All
- Source
- Cite
- Save
Citations (2)
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Comprehensive genomic profiling of malignant peritoneal mesothelioma (MPeM) reveals key genomic alterations (GAs) distinct from malignant pleural mesothelioma (MPM).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)